Synergistic strategies for glioblastoma treatment: CRISPR-based multigene editing combined with immune checkpoint blockade

Abstract Glioblastoma (GBM) is a primary brain tumor known for its high levels of aggressiveness and resistance to current treatments such as radiotherapy and chemotherapy. As a result, there is a pressing need for innovative therapeutic approaches to combat GBM. Thus, we have developed an engineere...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Xiaolin Liu, Xiao Liu, Xiaonan Luo, Maorong Zhu, Nannan Liu, Juan Li, Qi Zhang, Cheng Zou, Yuxin Wu, Zhengcong Cao, Shuangxin Ma, Weizhong Wang, Guangzhao Yang, Jintao Gu, Wei Liu, Meng Li, Anan Yin, Yalong He, Wei Lin
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	BMC 2025-02-01
Saila:	Journal of Nanobiotechnology
Gaiak:	Glioblastoma Immunotherapy CRISPR/Cas9 Gene editing All-in-one
Sarrera elektronikoa:	https://doi.org/10.1186/s12951-025-03112-8
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!